ð»ââïžâš ã»ã®ãŒã® Longevity è¬åº§ãéè¬ãã âšð»ââïž
ð§žãããããŸã¡ãããLongevityã£ãŠçµå±ãã¢ã³ããšã€ãžã³ã°ãšã¯éãã®ïŒ ãµããªãšãé«çŽã¯ãªãŒã ã®è©±ïŒã
ð»ââïžãïŸïœ«ïŸïœ«ãããã£ãããã質åããã®ãã¢ã³ããšã€ãžã³ã°ãšèããš”ã·ã¯ãæ¶ã””è¥è¿ãã®éæ³”ã¿ãããªé¿ããããããLongevityã®æ¬è³ªã¯ããã§ã¯ãªãã®ãããLongevityãšã¯ãèåãšããçŸè±¡ãäœã®äžã§ã©ãé²ãã®ããç§åŠçã«çè§£ããŠãæ¥åžžã®ç©ã¿éããæé©åããŠããèãæ¹ãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ð§žãè¥è¿ãã®éæ³ãããªããŠãä»çµã¿ãç¥ã£ãŠå¯Ÿçãããã£ãŠããšãïœã
ð»ââïžãããããããšãããéæ³ã®è¬ãæ¢ãããããªãã”ãªãèããã®ã”ãçè§£ããŠãæ¯æ¥ã®æ®ããã®äžã§å°ããã€æãæã£ãŠããããããLongevityã®çé«ãªã®ãããâšã
ð»ââïžâïž Longevityã®ãäºå±€æ§é ããç¥ãã®ãã
ããŠããã®Longevityãšããåéãå®ã¯å€§ããäºã€ã®å±€ã«åããŠçè§£ãããšéåžžã«ã¹ãããªããã®ããã
第1å±€ã¯ãåºç€èåçç©åŠïŒHallmarks of AgingïŒããšåŒã°ããé åã§ã现èãçµç¹ã®äžã§èåãã©ãé²ãããæ±ãåŠåãããããã¯2013幎ã«ã¹ãã€ã³ã»ãªããšã倧åŠã®Carlos López-OtÃnããåŠè¡èªãCellãã«çºè¡šããè«æãåºçºç¹ã«ãªã£ãŠããã®ããã圌ãã¯ãŸã9ã€ã®ãèåã®ç¹åŸŽïŒHallmarksïŒããå®çŸ©ããã®ãããããã®åŸ10幎éã®ç ç©¶ææãèžãŸãã2023幎ã«åãããCellãèªã§æ¹èšçãçºè¡šãã3ã€ã远å ããŠåèš12ã®ç¹åŸŽã«æ¡åŒµããã®ãããã
ð§žã9ã€ã ã£ãã®ã12ã«å¢ããã®ïŒ 10幎ã§ãããªã«ç ç©¶ãé²ãã ãã ã
ð»ââïžãããããã远å ããã3ã€ã¯”ãªãŒããã¡ãžãŒã®æ©èœäžå 𔔿 ¢æ§çç””ãã£ã¹ãã€ãªãŒã·ã¹ïŒè žå 现èå¢ã®ä¹±ãã§ãããããå ã®9ã€ã®äžã«å«ãŸããŠããæŠå¿µããã粟å¯ã«ç¬ç«ããããã®ãªã®ãããã¡ãªã¿ã«López-OtÃnããå®ããHallmarkã®èªå®åºæºã¯3ã€ãã£ãŠã®ãâ å 霢ãšãšãã«çŸããããšãâ¡ãããå®éšçã«æªåããããšèåãå éããããšãâ¢æ²»ççã«ä»å ¥ããã°èåãé ããããæ¢ããããå Žåã«ãã£ãŠã¯é転ãããããããšââãã®3æ¡ä»¶ãæºãããã®ã ããHallmarkãšèªããããã®ããð»ââïžã£ïŸïŸïœŒïœ¯ã
ãããŠç¬¬2å±€ããèšåºLongevityãã§ã第1å±€ã§è§£æãããèåã¡ã«ããºã ã®ç¥èã䜿ã£ãŠãå®éã«ç æ°ãæ©èœäœäžãé²ããå¥åº·å¯¿åœãå»¶ã°ãããã®å®è·µçã¢ãããŒããæ±ãåéãªã®ãããã€ãŸãã第1å±€ããäœã®äžã§äœãèµ·ããŠããããã®å°å³ãªãã第2å±€ã¯ããã®å°å³ãèŠãªãããæ¥åžžçæŽ»ã§ã©ãåãããã®ããã²ãŒã·ã§ã³ãšããããã¢ãã
ð»ââïžð¬ 第1å±€ïŒåºç€èåçç©åŠ ïœ 12ã®Hallmarks of Aging ïœ
åºç€èåçç©åŠããŸãæããŠãããã®ã¯ãèåã¯åäžã®åå ã§èµ·ããã®ã§ã¯ãªããããã€ãã®å°ããªç°åžžã絡ã¿åããæªåŸªç°ã圢æããªããé²è¡ãããšããããšãªã®ãããããããã¯12ã®Hallmarkãã²ãšã€ãã€ããããäžå¯§ã«è§£ãã»ãããŠããããã
âïžâ ã²ãã äžå®å®æ§ïŒGenomic InstabilityïŒ
ãããã®äœã®çްèã¯æ¯æ¥èšå€§ãªæ°ã®DNAæå·ãåããŠããã®ããã玫å€ç·ã掻æ§é žçŽ ã代è¬ã®å¯ç£ç©ããããŠçްèåè£æã®ã³ããŒãšã©ãŒãè¥ããã¡ã¯ä¿®åŸ©ã·ã¹ãã ããã£ããåããŠå·ãçŽããŠãããã®ãããã幎ãéãããšãã®ä¿®åŸ©ã®ç²ŸåºŠãèœã¡ãŠããã®ããã
ããšãããªããèšèšå³ãäœååãã³ããŒãç¶ãããã¡ã«ãã ãã ãæåãããããããç·ããºã¬ããããŠãããããªãã®ã¢ãã®ãLópez-OtÃnãã®2013幎ã®è«æã§ããDNAä¿®åŸ©æ©æ§ã®æ¬ æãããŠã¹ã®æ©èåãåŒãèµ·ããããšã瀺ãããŠããããéã«DNA修埩é¢é£ã®ã¿ã³ãã¯è³ªBubR1ãéå°çºçŸãããããŠã¹ã§ã¯å¥åº·å¯¿åœãå»¶ã³ãããšãå ±åãããŠããã®ãããããã«ãåºä¹³é¡ã®çš®éæ¯èŒç ç©¶ã«ããã°ãé·å¯¿ãªçš®ã»ã©DNA修埩ã¡ã«ããºã ã匷åãããŠãããSIRT6ãšããã¿ã³ãã¯è³ªããã®çš®éå·®ã«å€§ããå¯äžããŠããå¯èœæ§ãææãããŠããããã
ð§žãã€ãŸãDNAã®ä¿®çå·¥ãç²ããŠãã¹ãå¢ããã£ãŠããšã ããèšèšå³ãå£ãããããããå·¥å Žããããããªãããã
ð»ââïžããã®éããããã²ãã äžå®å®æ§ã¯ããã®ãªã¹ã¯äžæãšãçŽçµããŠããããä»ã®ãã¹ãŠã®Hallmarkã®åå°ã«ããªã£ãŠããã®ãããâšã
âïžâ¡ ããã¡ã¢ççž®ïŒTelomere AttritionïŒ
æè²äœã®æ«ç«¯ã«ã¯ããã¡ã¢ãšããä¿è·ãã£ãããã€ããŠããã®ãããéŽçŽã®å 端ã«ãã©ã¹ããã¯ã®ã«ããŒãã€ããŠããã®ãæ³åããŠããããšãããããããã®ã现èãåè£ãããã³ã«ãã®ãã£ãããå°ããã€çããªããäžå®ä»¥äžçããªããšçްèã¯ããåè£ã§ããªããªãã®ããã
ããã§æ³šç®ãã¹ãã¯ãããã¡ã©ãŒãŒãšããé µçŽ ã®ååšãããããã¡ã©ãŒãŒã¯ããã¡ã¢ã®é·ããç¶æã»ä¿®åŸ©ããé µçŽ ãªã®ããããéåžžã®äœçްèã§ã¯ã»ãšãã©æŽ»æ§åãããŠããã¬ã®ãããããã¡ã©ãŒãŒãæ¬ æãããããŠã¹ã§ã¯æ©æèåã確èªãããŠãããã2025幎ã®ç ç©¶è«æã§ã¯ãããã¡ã¢ççž®ããã12ã®Hallmarkã®äžã§å¯äžã®ãåå ãã§ãããä»ã¯ãã¹ãŠãã®çµæã§ãããšãã倧èãªä»®èª¬ãŸã§æåºãããŠããããããã®ä»®èª¬ãæ£ãããã©ããã¯ãŸã è°è«ã®éäžããããããã¡ã¢ãèåã®äžå¿çãªåœ¹å²ãæ ã£ãŠããã®ã¯ééããªãã®ããã
ð§žãéŽåºãããæžã£ãŠããã®ã«è¿ããã ããæ©ãã°æ©ãã»ã©èããªã£ã¡ããã
ð»ââïžãïŸïœ«ïŸïœ«ããŸãã«ããããã€ã¡ãŒãžãããéŽåºãå®å šã«ããæžã£ãããããæ©ããªããªãã¢ããïŒ çŽ°èãåãã§ãããã¡ã¢ãéçãŸã§çããªããšåè£ã忢ããèå现èïŒã»ããã»ã³ãã»ã»ã«ïŒãžãšå€è²ããã®ãããã
âïžâ¢ ãšããžã§ããã£ãã¯å€åïŒEpigenetic AlterationsïŒ
DNAã®é åãã®ãã®ã¯å€ãããªããŠãããã©ã®éºäŒåããã€ãã©ã®ããã䜿ããããå¶åŸ¡ããã¹ã€ããã®äœç³»ãçã£ãŠããçŸè±¡ãããšããžã§ããã£ãã¯å€åãªã®ãããå æçš¿ã§ã楜èã¯åãã§ããæŒå¥ã®ãããã厩ããŠããããšè¡šçŸãããŠãã£ãããããã¯éåžžã«ç確ãªããšãããã®ã
å ·äœçã«ã¯DNAã®ã¡ãã«åãã¿ãŒã³ã®å€åããã¹ãã³ã®ã¢ã»ãã«åç°åžžãå 霢ãšãšãã«èç©ããŠããã®ãããDNAã¡ãã«åã®ãã¿ãŒã³ã¯ããŸããçç©åŠç幎霢æèšïŒãšããžã§ããã£ãã¯ã¯ããã¯ïŒããšããŠåºã䜿ãããŠããã»ã©ã§ãå®å¹Žéœ¢ãšçç©åŠç幎霢ã®ã®ã£ãããæž¬ãææšã«ãªã£ãŠããã®ããã
éèŠãªã®ã¯ãDNAå€ç°ãšéã£ãŠãšããžã§ããã£ãã¯å€åã¯çè«äžã¯å¯éçã ãšããããšããã2013幎ã®López-OtÃnãã®åè«æã§ãããã¹ãã³è±ã¢ã»ãã«åé µçŽ é»å®³å€ã®æäžã«ãã£ãŠå 霢ã«äŒŽãèšæ¶é害ãããŠã¹ã§åé¿ãããäºäŸãããã¹ãã³ã¢ã»ãã«ãã©ã³ã¹ãã§ã©ãŒãŒé»å®³å€ãæ©èçããŠã¹ã®å¯¿åœã延䌞ããäºäŸã玹ä»ãããŠããã®ãããããã«é©ãã¹ãããšã«ãç·è«ïŒC. elegansïŒã§ã¯ç¹å®ã®ã¯ãããã³ä¿®é£Ÿãæäœããããšã§ã芪ããåãžã®ãé·å¯¿ã®ãšããžã§ããã£ãã¯èšæ¶ããäžä»£ãè¶ ããŠäŒéãããããšãçºèŠãããŠããããã
ð§žãããéºäŒåã®ã¹ã€ããã£ãŠæ»ããã®ïŒ ããã£ãŠããããªãïŒã
ð»ââïžããããïŒ ã ãããããšããžã§ããã£ã¯ã¹ã¯Longevityç ç©¶ã§æãããããªé åã®ã²ãšã€ãªã®ãããéåãæé£ãç¹å®ã®æ€ç©ç±æ¥ååç©ããšãã²ãã ã®”åããã°ã©ãã³ã°”ã«å¯äžããå¯èœæ§ãææãããŠããããðã
âïžâ£ ããããªã¹ã¿ã·ã¹ã®ç Žç¶»ïŒLoss of ProteostasisïŒ
äœå ã®ã¿ã³ãã¯è³ªã¯äœãããæ£ããæããããŸããæ©èœãæãããäžèŠã«ãªã£ããåè§£ã»ãªãµã€ã¯ã«ããããšãã粟å¯ãªãµã€ã¯ã«ã®äžã§ç®¡çãããŠããã®ããããã®å質管çã·ã¹ãã ããããããªã¹ã¿ã·ã¹ããšåŒã¶ã®ããããå 霢ãšãšãã«ãã®ä»çµã¿ã匱ããªãã®ããã
å æçš¿ã®ãå·¥å Žã®å質管çãèœã¡ãŠãäžè¯åãå¢ããç¶æ ããšããããšãã¯å®ã«èŠäºãªã®ãããæãããã¿ã«å€±æããç°åžžã¿ã³ãã¯è³ªãèç©ãããšãããèªäœãæ¯æ§ãæã¡ãç¹ã«è³ã«ãããŠã¯ã¢ã«ããã€ããŒç ã®ã¢ããã€ãβãããŒãã³ãœã³ç ã®Î±-ã·ãã¯ã¬ã€ã³ã®ãããªåéäœãšããŠç¥çµçްèãç Žå£ããŠããã®ããã
ð§žãè³ã®ç æ°ãšçŽçµããŠããã âŠæããã
ð»ââïžããããªã®ããããããã®ãããªãã§ããŒã«ã®æåã鿬 çæé£ïŒã€ã³ã¿ãŒãããã³ããã¡ã¹ãã£ã³ã°ïŒããããŠãã£ãããšããç¡ç ãããããªã¹ã¿ã·ã¹ã®ç¶æã«å¯äžããå¯èœæ§ã瀺åãããŠãããããç¡ç äžã«è³ã®ã°ãªã³ããã£ãã¯ã»ã·ã¹ãã ãæŽ»æ§åããŠãç°åžžã¿ã³ãã¯è³ªãæŽãæµããŠããããšããç ç©¶ãããã®ãããç¡ç ã¯æ æ°ã§ã¯ãªãã现èã®ã¡ã³ããã³ã¹æéãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžâ€ ãªãŒããã¡ãžãŒäžå šïŒDisabled MacroautophagyïŒ
ããã2023å¹Žã®æ¹èšã§å ã â£ã®ããããªã¹ã¿ã·ã¹ã®äžéšãšããŠæ±ãããŠãããã®ããç¬ç«ææ ŒããHallmarkããããªãŒããã¡ãžãŒãšã¯ã现èå ã®å€ããªã£ããå£ãããããéšåãèã§å ã¿èŸŒã¿ããªãœãœãŒã ïŒåè§£å·¥å ŽïŒã«éãã§åŠåãããªãµã€ã¯ã«ã»ã·ã¹ãã ã®ããšãªã®ããã
López-OtÃnããç¬ç«ãããçç±ã¯æå¿«ã§ããªãŒããã¡ãžãŒã¯ã¿ã³ãã¯è³ªã ãã§ãªããè質å°èãã°ãªã³ãŒã²ã³ãããã«ã¯æ©èœäžå šã«é¥ã£ãããã³ã³ããªã¢äžžããšïŒãããã¡ãžãŒïŒãä»ã®ãªã«ã¬ãã©ãŸã§åŠç察象ã«ããŠãããããããã¿ã³ãã¯è³ªã ããæ±ãããããªã¹ã¿ã·ã¹ãšã¯å®åç¯å²ãéãã®ããã
å æçš¿ã®ã现èå ã®æé€æ©èœãéãããšãã衚çŸã¯ããããããããããå°ãæ£ç¢ºã«èšãã°ããªãµã€ã¯ã«å·¥å Žã®åŠçèœåãèœã¡ãŠããŽããå·¥å Žå ã«æºãŸã£ãŠããç¶æ ãããã®ããªãŒããã¡ãžãŒé¢é£ã¿ã³ãã¯è³ªAtg5ãéå°çºçŸãããããŠã¹ã§ã¯ã寿åœãå¥åº·å¯¿åœã延䌞ãããšããå ±åãããããã
ð§žãæé€ããªããšéšå±ãæ±ããã®ãšåãã ãã
ð»ââïžãïŸïœ¯ïŸïœ°ããã®éãããããããŠæé£ïŒãã¡ã¹ãã£ã³ã°ïŒã¯ãªãŒããã¡ãžãŒã掻æ§åãããæãæè»œãªæ¹æ³ã®ã²ãšã€ãšããŠç¥ãããŠããããã
âïžâ¥ æ 逿ç¥ç°åžžïŒDeregulated Nutrient SensingïŒ
ãããã®çްèã«ã¯ãããŸæ é€ãè±å¯ããè¶³ããªããããæç¥ããã»ã³ãµãŒãåãã£ãŠããã®ããã代衚çãªã®ãmTORçµè·¯ãã€ã³ã¹ãªã³/IGF-1ã·ã°ãã«ãAMPKãªã©ã§ãããããæ é€ç¶æ ã«å¿ããŠçްèã®æé·ã»åè£ã»ä¿®åŸ©ã®ãã©ã³ã¹ã調æŽããŠããã®ããã
ãšãããå 霢ãšãšãã«ãã®ã»ã³ãµãŒã®ç²ŸåºŠãèœã¡ãã¢ã¯ã»ã«ãšãã¬ãŒãã®å æžããããŠããã®ãããåžžã«ãæ é€ãã£ã·ãã ããæé·ããããšããã·ã°ãã«ãåºç¶ãããšã现èã¯ä¿®åŸ©ããã墿®ãåªå ããŠããŸããçµæçã«ãããè¥æºã2åç³å°¿ç ã®ãªã¹ã¯ãé«ãŸãã®ããã
mTORC1è€åäœãé»å®³ããã©ããã€ã·ã³ãã¢ãã«çç©ã§å¯¿åœå»¶äŒžå¹æã瀺ããã«ããªãŒå¶éïŒCRïŒãCRæš¡å£è¬ã§ããã¡ããã«ãã³ãæ 逿ç¥çµè·¯ã®æ£åžžåã«å¯äžããããšãå€ãã®ç ç©¶ã§ç¢ºèªãããŠããããã
ð§žããã£ãšé£ã¹æŸé¡ãã€ãã³ã°ã«ããã¿ãããªç¶æ ã£ãŠããšïŒã
ð»ââïžãïŸïœ«ïŸïœ«ãé¢çœãããšãããã现èã¬ãã«ã§ãã£ãš”é£ã¹æŸé¡ã¢ãŒã”ãè§£é€ãããªããªãã€ã¡ãŒãžã¢ãã®ãã ããããé©åºŠãªç©ºè ¹æéãèšããããšããé£ã¹ãããªãããšãLongevityã«ãšã£ãŠéèŠãªã®ãããã
âïžâŠ ããã³ã³ããªã¢æ©èœé害ïŒMitochondrial DysfunctionïŒ
ããã³ã³ããªã¢ã¯çްèã®ãšãã«ã®ãŒå·¥å Žãããããã§ATPïŒçްèã®ãšãã«ã®ãŒé貚ïŒãäœãããã®ããããåæã«æŽ»æ§é žçŽ çš®ïŒROSïŒãå¯ç£ç©ãšããŠçæãããã®ããã
ãã€ãŠã¯ã掻æ§é žçŽ ãèåã®äž»ç¯ããšãã”ããªãŒã©ãžã«ã«èª¬”ãäž»æµããã£ããããã®10幎ã§å€§ããèŠæ¹ãå€ãã£ãã®ãããããã³ã³ããªã¢ã®æ©èœãæå¶ããŠROSãå¢ãããã»ããããã£ãŠæçã«ãªãã±ãŒã¹ãçºèŠãããããŸã§ã¯ROSã¯åãªã”æªè ”ã§ã¯ãªãã现èã¹ãã¬ã¹ãç¥ãããã·ã°ãã«ååãšããŠã®åŽé¢ãéèŠãããŠããã®ããããããããããã«ãã·ã¹ããšåŒã¶ã®ããããè¥ãææã®è»œåºŠãªããã³ã³ããªã¢ã¹ãã¬ã¹ã¯çްèã®é©å¿åãé«ããçåãä¿é²ãã广ãããã®ããã
ãããå 霢ã«ãã£ãŠããã³ã³ããªã¢ã®æ°é³ä»£è¬ïŒãããã¡ãžãŒã«ããå ¥ãæ¿ãïŒãæ»ããšãæ©èœäžå šã®ããã³ã³ããªã¢ãå± åº§ãç¶ãããšãã«ã®ãŒç£çå¹çãäœäžããã®ãããç²ãããããçåäœäžã®æ ¹åºã«ã¯ãã®çŸè±¡ãããã®ããããçŸåšæ³šç®ãããŠããä»å ¥çãšããŠã¯ãNAD+ããŒã¹ã¿ãŒïŒNMNãNRãªã©ïŒããããã¡ãžãŒèªå°å€ãããããã
ð§žãçºé»æãèæœåããŠãé»åäžè¶³ãšææ°ã¬ã¹ãå¢ããã¿ããã ãã
ð»ââïžããŸãã«ãã®éãããããããŠçºé»æã®ç«ãŠæ¿ãå·¥äºãããŸããããªããªãããããããã³ã³ããªã¢æ©èœéå®³ã®æ žå¿ãªã®ããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžâ§ 现èèåïŒCellular SenescenceïŒ
现èèåãšã¯ã现èãå®å šã«æ»ã¬ããã§ã¯ãªãããããåè£ããããæ¬æ¥ã®æ©èœãæãããªããªã£ãç¶æ ã§å± 座ãç¶ããçŸè±¡ãããå æçš¿ã®ãåŒéããã®ã«è·å Žã«æ®ã£ãŠãåšå²ã®ä»äºãä¹±ã瀟å¡ããšããããšãã¯ç§éžããããããïŸïœ«ïŸïœ«ã
ãªããããªä»çµã¿ãããããšãããšãè¥ãææã®çްèèåã¯ããæå¶æ©æ§ãšããŠæ¥µããŠæçšãªã®ãããæå·ãåãã现èãæŽèµ°çã«å¢æ®ããã®ãé²ããå·ã®ä¿®åŸ©ã«ãè²¢ç®ãããããã幎霢ãéãããšãèå现èãå ç«ç³»ã«ãã£ãŠå¹ççã«é€å»ãããªããªããèç©ããŠããã®ããã
åé¡ã¯èå现èãåæ³ãããSASPïŒçްèèåé¢é£åæ³è¡šçŸåïŒããšåŒã°ããççæ§å åã®ã«ã¯ãã«ããããã®SASPãåšå²ã®æ£åžžçްèã«ãŸã§ççãæ³¢åãããçµç¹å šäœã®æ©èœãäœäžãããã®ãããããŸæ³šç®ãããŠãããã»ããªãã£ã¯ã¹ããšããè¬å€ã¯ããã®å± 座ãç¶ããèå现èã ããéžæçã«é€å»ããæŠç¥ã§ãããŠã¹ã§ã¯èº«äœæ©èœã®æ¹åãšå¯¿åœå»¶äŒžãå ±åãããŠããããã
ð§žãæªã现èã ããçãæã¡ã«ããè¬ããããã ïŒã
ð»ââïžããããããŸã ããã§ã®å€§èŠæš¡ãªèšåºè©Šéšã¯éåã°ããããšã¯ãããéåãã»ããªãã£ã¯ã¹çãªå¹æãæã€ãšããç ç©¶ããã£ãŠã®ãäœãåããããšã§èå现èã®ã¯ãªã¢ã©ã³ã¹ãä¿é²ãããå¯èœæ§ã瀺åãããŠããã®ãããâšã
âïžâš å¹¹çŽ°èæ¯æžïŒStem Cell ExhaustionïŒ
幹现èã¯ãå·ã€ããçµç¹ã修埩ããããã«æ°ãã现èãäŸçµŠãããè£å éšéãã®ãããªååšãªã®ããã骚é«ã«ããéè系幹现èã¯éªšãè»éªšãçèã®çްèã«ååã§ããããç®èãè žã®å¹¹çްèã¯æ¥ã ã®çްèã¿ãŒã³ãªãŒããŒãæ¯ããŠããã®ããã
ãšãããå 霢ãšãšãã«ããã®å¹¹çްèèªäœãæ°ãæžãããååèœåãäœäžããŠããã®ãããä¿®çèŠå¡ãæžã£ãŠã建ç©ãèæœåããŠãçŽããªããªãç¶æ ããã®ã
ð§žãä¿®çå·¥ãè¶³ããªããªã£ãããããçŽãããããªããããã
ð»ââïžããã®éããããããŸåçå»çã®åéã§ã¯”现èãªããã°ã©ãã³ã°”ãšããæè¡ã«å€§ããªæåŸ ãå¯ããããŠãããããäœçްèã4ã€ã®è»¢åå åïŒå±±äžå åïŒOct4, Sox2, Klf4, c-MycïŒã«ãã£ãŠå€èœæ§å¹¹çްèã«æ»ãæè¡ããã2012幎ã«ããŒãã«è³ãåè³ããå±±äžäŒžåŒ¥ææã®iPS现èæè¡ããLongevityã®æèã§ãåã³èå ãæµŽã³ãŠããã®ãããðã
âïžâ© 现èéã³ãã¥ãã±ãŒã·ã§ã³ç°åžžïŒAltered Intercellular CommunicationïŒ
现èã¯ã²ãšã€ã²ãšã€ãå€ç«ããŠååšããŠããããã§ã¯ãªãããã«ã¢ã³ããµã€ãã«ã€ã³ããšã¯ãœãœãŒã ãªã©ããŸããŸãªã·ã°ãã«ååãä»ããŠåžžã«ãäŒè©±ãããŠããã®ããããã®é£çµ¡ç¶²ãä¹±ãããšãããå Žæã§èµ·ããç°åžžãå šèº«ã«æ³¢åããŠããŸãã®ããã
å æçš¿ã®ãäœã®äžã®é£æºãæªããªããççãæ©èœäœäžãåºããããããªãããšãã説æã¯ç確ããããè£è¶³ãããªãã°ããã®ç°åžžã¯ç¥çµç³»ã»å åæ³ç³»ã»å ç«ç³»ã®äžè éã®ã¯ãã¹ããŒã¯ã®åŽ©å£ãšããŠçè§£ããã®ãæ£ç¢ºãªã®ããã
ð§žãäŒç€Ÿã§èšãã°ãéšçœ²éã®é£çµ¡ãã¹ãé »çºããŠãç¶æ ããªã
ð»ââïžãïŸïœ«ïŸïœ«ããŸãã«ãããããã¡ãŒã«ãå±ããªããé»è©±ãã€ãªãããªããäŒèšã²ãŒã ã§å 容ãããæ¿ããâŠãããªçµç¹åŽ©å£ãäœå ã§èµ·ããŠããã®ãããã
âïžâª æ ¢æ§ççïŒChronic InflammationïŒ ïœ 2023幎远å ïœ
å ã ã¯â©ã®çްèéã³ãã¥ãã±ãŒã·ã§ã³ç°åžžã®äžéšãšããŠæ±ãããŠãããã®ãã2023å¹Žã®æ¹èšã§ç¬ç«ããHallmarkãªã®ããããã€ã³ãã©ã¡ã€ãžã³ã°ïŒInflammagingïŒããšãåŒã°ãããã®çŸè±¡ã¯ãã¯ã£ãããšããææãå€å·ããªãã«ããããããã匱ãççãäœå ã§ãã£ãšããã¶ãç¶ããç¶æ ãæãã®ããã
å æçš¿ã®ãå°ããªç«äºããã£ãšããã¶ã£ãŠããç¶æ ããšããããšãã¯å®ã«ç§éžããã®ãè¡äžã®IL-6ïŒã€ã³ã¿ãŒãã€ãã³6ïŒæ¿åºŠã®äžæãé«éœ¢è ã®å šæ»äº¡çãšé¢é£ããŠããããšãå€§èŠæš¡ç ç©¶ã§ç€ºãããŠãããæ ¢æ§ççãã»ãŒãã¹ãŠã®å 霢é¢é£çŸæ£ã®å ±éåºç€ãšããŠæ©èœããŠããããšãããã£ãŠããã®ããã
ð§žãç«äºã®ç«çš®ããã£ãšæ¶ããªããªããŠãæãããâŠã
ð»ââïžããããããããæçççãªé£äºïŒãªã¡ã¬3èèªé žãç·é»è²éèãã¿ãŒã¡ãªãã¯ãªã©ïŒãšé©åºŠãªéåãååãªç¡ç ãéèŠãªã®ãããç«ãæ¶ãã®ã§ã¯ãªããç«çš®ãäœããªãçæŽ»ã倧äºãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
âïžâ« ãã£ã¹ãã€ãªãŒã·ã¹ïŒDysbiosisïŒ ïœ 2023幎远å ïœ
ãã¡ãã2023å¹Žã®æ¹èšã§æ°ãã«å ãã£ãHallmarkãããè žå 现èå¢ïŒãã€ã¯ããã€ãªãŒã ïŒã®ãã©ã³ã¹ãå 霢ãšãšãã«åŽ©ããŠããçŸè±¡ãæãã®ããã
è žå ã«ã¯æ°å åã®åŸ®çç©ãå ±çããŠãããæ¶åã»ä»£è¬ã»å ç«ã»ããã«ã¯è³ã®æ©èœïŒè žè³çžé¢ïŒã«ãŸã§åœ±é¿ãäžããŠããã®ãããå 霢ãšãšãã«è žå 现èã®å€æ§æ§ãäœäžããççãèªçºããèçš®ãå¢ãã代è¬ãå ç«ã«æªåœ±é¿ãåºããããªãã®ããã
泚ç®ãã¹ãç ç©¶ãšããŠãç³äŸ¿åŸ®çç©ç§»æ€ïŒFMTïŒãæ©èçããŠã¹ã®å¯¿åœãšå¥åº·å¯¿åœã®äž¡æ¹ã延䌞ããããšããå ±åããããããã€ãŸãè žå ç°å¢ãæŽããã ãã§èåã®é²è¡ãé ãããããå¯èœæ§ã瀺åãããŠããã®ããã
ð§žãè žå ã®äœæ°æ§æãä¹±ãããšã代è¬ãå ç«ããããããªããã ãã
ð»ââïžãããããã®ãçºé µé£åãé£ç©ç¹ç¶ããããŠäžå¿ èŠãªæçç©è³ªã®äœ¿çšãé¿ããããšã倧åãªã®ãããè žã¯”ç¬¬äºã®è³”ã©ããããLongevityã®æåç·åºå°ãšèšã£ãŠãéèšã§ã¯ãªãããâšã
ð»ââïžð 12ã®Hallmarkã¯åç¬ã§ã¯ãªããæªåŸªç°ãã§é²ã
ãããæ¥µããŠéèŠãªãã€ã³ããªã®ãããå æçš¿ã§ãææãããŠãã£ãããããã12ã®Hallmarkã¯ãã©ãã©ã«é²è¡ããã®ã§ã¯ãªããäºãã«çµ¡ã¿åã£ãŠæªåŸªç°ã圢æããã®ããã
ããšãã°ãããã³ã³ããªã¢æ©èœé害ïŒâŠïŒãé²ããšæŽ»æ§é žçŽ ãå¢ããŠæ ¢æ§ççïŒâªïŒãæªåããã®ãããççãæªåãããšDNAæå·ãèç©ãïŒâ ïŒãDNAæå·ã¯ãšããžã§ããã£ãã¯å€åïŒâ¢ïŒãå éãããã®ããããšããžã§ããã£ãã¯å€åãé²ããšçްèèåïŒâ§ïŒãå¢ããèå现èã®SASPãããã«ççãç œãâŠãšããããã«ããŸãã§ãããåãã®ããã«é£éããŠããã®ããã
ð§žãã²ãšã€åŽ©ãããšå šéšã«æ³¢åãããã âŠã
ð»ââïžããããããããã²ãšã€ã®Hallmarkã ãããã³ãã€ã³ãã§å©ãã®ã§ã¯ãªããè€æ°ã®Hallmarkã«åæã«ã¢ãããŒããã”å€è§çæŠç¥”ãéèŠãªã®ããããããŠãã®å€è§çæŠç¥ãããã第2å±€ã®èšåºLongevityãæ±ãé åãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ð»ââïžðª 第2å±€ïŒèšåºLongevity ïœ 12ã®å®è·µçã¢ãããŒã ïœ
第1å±€ã§èåã®å°å³ãæãããšããã§ããããã第2å±€ã®ãèšåºLongevityãã«å ¥ããããããã¯ç 究宀ã®è©±ã§ã¯ãªãããã¬ãã仿¥ããã®æ®ããã®äžã§å®è·µã§ããé åããã
ðâ éåïŒLongevityã®æåŒ·ä»å ¥
èšåºLongevityã®äžå¿ã¯ããªããšèšã£ãŠãéåãããéåãéèŠãªã®ã¯åã«ã«ããªãŒãæ¶è²»ããããã§ã¯ãªãã®ãããå¿èºæ©èœãçåãè¡ç³ãè¡å§ãè質ãççããŒã«ãŒãç¡ç ã®è³ªãæ°åã転åãªã¹ã¯ãŸã§ãäžåºŠã«å€ãã®é åãæ¹åãããããããæåŒ·ã®ä»å ¥ããšåŒã°ããã®ããã
ããã§å æçš¿ã®èè ãé¢çœãããšãèšã£ãŠããã®ãããLongevityèŠç¹ã§ã®éåã¯ãé«ããªã¥ãŒã ã»é«ééã»ææ°çŸkmã®èµ°ã蟌ã¿ãã§ã¯ãªããã軜ãè² è·ã§éãã»çãã¬ã¯é±60åã»æé žçŽ ã¯ãŸãŒã³2ã軞ã«ããŸã«HIITã»åºæ¬ãµããªã¯ã¯ã¬ã¢ãã³ãšãããã€ã³ã ãããšããã¢ãããŒããªã®ãããšãåè ã®ãŽãªãŽãªæ¹åŒããèŠãã°ããããªãã§å¹ããããªãã ãããšæãããã¡ããããç ç©¶ã瀺ããŠããã®ã¯ãŸãã«ãã®ãããã«ãã€æç¶å¯èœãªã¢ãããŒãã®æå¹æ§ãªã®ããã
ð§žããããããªã«å°ãªããŠããã®ïŒ ãã£ãšã¬ã³ã¬ã³ãããªãããã¡ããšæã£ãŠãã
ð»ââïžãïŸïœ¯ïŸïœ°ãã¬ã³ã¬ã³ããããããšããã£ãŠãªãŒããŒãã¬ãŒãã³ã°ã§ççãå¢ããå ç«ãäžãããæŽ»æ§é žçŽ ãéå°ã«ãªãã®ãããLongevityã®ãŽãŒã«ã¯”仿¥ã®ããã©ãŒãã³ã¹ãæå€§åããããš”ã§ã¯ãªãã”20幎åŸãèªåã®è¶³ã§æ©ããããš”ãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ðâ¡ å¿èºæ©èœ
å¿èºæ©èœïŒVO2maxïŒã¯å¯¿åœãç æ°ãªã¹ã¯ãšåŒ·ãçžé¢ããææšãªã®ããã倧äºãªã®ã¯äœéã®æ°åããããæ¯åããã«ããããéæ®µãäžããããæ©ãç¶ããããããšãã”åãã䜔ã§ããããšããã
ãŸãŒã³2æé žçŽ éåïŒäŒè©±ã§ãããããã®åŒ·åºŠãé·æéç¶æãããã¬ãŒãã³ã°ïŒãVO2maxã®åºäžãã«æã广çãšãããŠãããããã¯ããã³ã³ããªã¢ã®æ°çãšæ©èœæ¹åã«ãçŽçµããŠããã®ãããã€ãŸãã第1å±€ã®HallmarkâŠïŒããã³ã³ããªã¢æ©èœé害ïŒãžã®çŽæ¥çãªå¯Ÿçã«ããªã£ãŠããã®ãããã
ð⢠çåãšçè
çãã¬ã¯è¥è ã®è¶£å³ã§ã¯ãªãã®ãããç«ã€ãæ©ãã転ã°ãªããè·ç©ãæã€ãéæ®µãäžãâŠãããã®æ¥åžžç掻åäœïŒADLïŒã®åå°ãæ¯ããã®ãçåã§ãããèåŸã®èªç«ãå®ãæã確å®ãªææ®µã®ã²ãšã€ãªã®ããã
ãµã«ã³ããã¢ïŒå 霢ã«äŒŽãçéã»çåã®äœäžïŒã¯è»¢åã»éªšæã»å¯ãããã®æå€§ãªã¹ã¯å åã®ã²ãšã€ã§ãããäžåºŠå¯ãããã«ãªããšçåã®ååŸ©ã¯æ¥µããŠå°é£ã«ãªãã®ãããã€ãŸãçãã¬ã¯”æ»ã”ã§ã¯ãªã”å®ã”ã®æè³ãªã®ãããã
ð§žãçãã¬ã£ãŠèŠãç®ã®ããã ããããªãã£ããã ã
ð»ââïžãïŸïœ«ïŸïœ«ããã¡ããèŠãç®ã«ãå¹ãããLongevityã«ãããŠã¯”70æ³ã§èªåã®è¶³ã§æ è¡ã«è¡ãããã©ãã”ãå·Šå³ããèŠçŽ ãªã®ãããæªæ¥ã®èªåãžã®èŽãç©ãšæãã°ããããâšã
ð⣠æ é€
Longevityã®é£äºã¯ãç¹å¥ãªéæ³ã®é£äºã§ã¯ãªãã®ãããåºæ¬ååã¯æ¥µããŠã·ã³ãã«ã§ãèªç¶ã«è¿ãé£åãå¢ãããå 工床ã®é«ãé£åãæžããããšãããã«å°œããã®ããã
å ·äœçã«ã¯ãéèãæç©ãè±ãå šç²ç©ç©ãããããªã©ãå¢ãããå å·¥é£åãç ç³ã®å€ã飲ã¿ç©ãå å·¥èãé£ã¹ãããæžãããå°äžæµ·é£ãLongevityç ç©¶ã§ç¹°ãè¿ãæšå¥šãããã®ãããã®ååãèªç¶ã«æºãããŠãããããªã®ããã
ð§žãç¹å¥ãªãµããªãšãé«ãã¹ãŒããŒããŒãã¯ïŒã
ð»ââïžãåºæ¬ãããããã«ããŠãµããªã«é Œãã®ã¯ãåºç€å·¥äºãããã«å±æ ¹ã ã豪è¯ã«ããå®¶ã®ãããªãã®ããããŸãã¯å°å³ã§ã確å®ãªé£ç¿æ £ã®æ¹åããã¢ãð»ââïžã£ïŸïŸïœŒïœ¯ã
ð†ç¡ç
ç¡ç ã¯ããã é·ãå¯ãã°ãããšãããã®ã§ã¯ãªãã®ãããæè¿ã®ç ç©¶ã§ã¯ãç¡ç æéã ãã§ãªãèŠåæ§ã極ããŠéèŠã§ããããšãããã£ãŠããã®ãããå¹³æ¥ãšäŒæ¥ã§ç掻ãªãºã ã倧ãã厩ãããèµ·ããæå»ããªãã¹ãããããããšã倧åãªã®ãããã
ç¡ç äžã«ã¯ã°ãªã³ããã£ãã¯ã»ã·ã¹ãã ãæŽ»æ§åããŠããããªã¹ã¿ã·ã¹ãç¶æãïŒâ£ïŒããªãŒããã¡ãžãŒãä¿é²ããïŒâ€ïŒãæé·ãã«ã¢ã³ãåæ³ãããŠå¹¹çްèã®æ©èœãæ¯ãïŒâšïŒãççããŒã«ãŒãäœäžããïŒâªïŒãã€ãŸãç¡ç ã¯è€æ°ã®Hallmarkã«äžåºŠã«ã¢ãããŒããã”ç¡æã®äžèœè¬”ãªã®ããã
ð⥠äœé管ç
äœé管çã«ãããŠéèŠãªã®ã¯ãäœéèšã®æ°åã ãã§ãªããã©ãã«èèªãã€ããŠãããããªã®ããããšãã«ãè ¹ãŸãããã€ãŸãå èèèªãå€ãç¶æ ã¯ãè¡å§ãè¡ç³ãè質ãççããŒã«ãŒãã¹ãŠã«æªåœ±é¿ãåãŒããå¥åº·å¯¿åœã«ãšã£ãŠæ¥µããŠäžå©ãªã®ããã
å èèèªã¯ããèªäœãççæ§ãµã€ãã«ã€ã³ãåæ³ãã”å åæ³èåš”ã®ããã«æ¯ãèãããšãããã£ãŠãããã€ãŸã第1å±€ã®HallmarkâªïŒæ ¢æ§ççïŒã®ç«çš®ãäœå ã«æ±ãç¶ããŠããç¶æ ãªã®ããã
ð§žãç©ããŠãããã«èŠããŠããè ¹ã ãåºãŠã”é ãè¥æº”ãå±ãªãã£ãŠããšïŒã
ð»ââïžããã®éããããBMIã ãã§ã¯èŠããªãå èèèªéãããLongevityã®ã«ã®ãæ¡ã£ãŠããã®ãããã
ð⊠è¡å§ã»è¡ç³ã»è質ã®ç®¡ç
ãããã®æ°å€ã¯èªèŠçç¶ãä¹ãããŸãŸãé·å¹ŽãããŠè¡ç®¡ãå¿èãè³ãè èãéãã«å·ããŠããã®ãããèåãæ©ããç æ°ã®å€ãã¯ãããããéãã«é²ãçæŽ»ç¿æ £ç ãšåŒ·ãçµã³ã€ããŠããã®ããã
é«è¡å§ãé«è¡ç³ãè質ç°åžžã¯å¥ã ã®ç æ°ã®ããã«èŠããããå®ã¯ãã¹ãŠãã¡ã¿ããªãã¯ã»ã·ã³ãããŒã ããšããå ±éã®åå£ã®äžã«æãç«ã£ãŠããã®ããããããŠãã®åå£ã¯Hallmarkâ¥ïŒæ 逿ç¥ç°åžžïŒãšâªïŒæ ¢æ§ççïŒã«çŽçµããŠãããã€ãŸãã第1å±€ã®åºç€çç©åŠãšç¬¬2å±€ã®èšåºå®è·µãããã§ã¯ãã¹ããã®ããã
ðâ§ è³ã®LongevityïŒèªç¥æ©èœïŒ
èªç¥çäºé²ã¯è³ãã¬ã ãã§ã¯ãªãã®ãããéåãè¡å§ç®¡çãç³å°¿ç äºé²ãç¡ç ã瀟äŒåå ããã€å¯Ÿçãè³ãç®ã®ã±ã¢ãŸã§å«ããç·åæŠã§ããè³ã¯äœããåãé¢ãããç¹å¥ãªèåšã§ã¯ãªããå šèº«ã®åœ±é¿ãåããèåšãªã®ããã
ð§žãã¯ãã¹ã¯ãŒãããºã«ã ããããã¡ãªã®ïŒã
ð»ââïžãïŸïœ«ïŸïœ«ãã¯ãã¹ã¯ãŒããæªãã¯ãªãããããã ãã§èªç¥çãé²ããããšãããšäžååãããäœãåããã人ãšäŒããããç ããè¡ç®¡ã®å¥åº·ãä¿ã€âŠããããã¹ãŠãèªç¥æ©èœã®ç¶æã«å¿ èŠãª”è³ãžã®æè³ããŒããã©ãªãª”ãªã®ãããðã
ðâš è³ãšç®ã®å¥åº·
ããã¯èŠèœãšãããã¡ããããéåžžã«éèŠãªé åãªã®ãããèããã«ãããèŠãã«ããç¶æ ãæŸçœ®ãããšã掻åéãæžãã人ãšã®äº€æµãæžããèªç¥æ©èœã«ãæªåœ±é¿ãåºããããªãã®ããã
è£èŽåšãçŒç§å蚺ã¯ãçæŽ»ã®è³ªãã®åé¡ã ãã§ã¯ãªããèªç«ãšè³ã®å¥åº·ãå®ãè¡åãªã®ããããè¿å¹Žã®ç ç©¶ã§ã¯ãé£èŽã¯èªç¥çã®æå€§ã®ä¿®æ£å¯èœãªãªã¹ã¯å åã®ã²ãšã€ãšãããŠããããã
ð⩠瀟äŒçã€ãªãã
Longevityã¯é£äºãéåã ãã®è©±ã§ã¯ãªãã®ããã人ãšã®äº€æµãæžããå€ç«ãé²ããšãæ°åã®èœã¡èŸŒã¿ã掻åéäœäžãèªç¥æ©èœäœäžãããã«ã¯æ»äº¡ãªã¹ã¯ã®äžæã«ãŸã§ã€ãªããããšãå€§èŠæš¡ç ç©¶ã§ç€ºãããŠããã®ããã
ð§žããŒã£ã¡ã¯ããã ã«æªãã£ãŠããšâŠïŒã
ð»ââïžãã¡ãã£ãšèº«ãèããªãèšãæ¹ããããç§åŠçã«ã¯ããããããšã¢ãã人ãšã®ã€ãªããã¯å ç«æ©èœãççã¬ãã«ã«ãŸã§åœ±é¿ããããšãããã£ãŠãããé£äºãéåãæŽããã®ãšåããããã誰ããšäŒã£ãŠè©±ãæéãæèçã«ç¢ºä¿ããããšã倧äºãªã®ãããâšã
ð⪠ã¡ã³ã¿ã«ãã«ã¹
æ°åã®èœã¡èŸŒã¿ãäžå®ãææ¬²äœäžãã幎ã®ãããã§çã¥ããŠããŸããšãçæŽ»å šäœã厩ãããããªãã®ãããLongevityãç®æãã®ã¯é·ãçããããšã§ã¯ãªããå¿ãå«ããŠæ©èœçã«çããããšãªã®ããã
ãã€ç¶æ ã¯é£æ¬²ãéåææ¬²ã瀟äŒåå ãç¡ç ã®ãã¹ãŠã«åœ±é¿ããçµæçã«ä»ã®ãã¹ãŠã®èšåºLongevityã®æ±ã匱äœåãããã®ãããã¡ã³ã¿ã«ãã«ã¹ã®ã±ã¢ã¯Longevityã®ãå¿ ä¿®ç§ç®ããªã®ãããã
ðâ« ç°å¢
空æ°ã®æªããéšé³ãæãå¯ããäœã¿ã«ããç°å¢ã¯ãå¿èãè¡ç®¡ãåŒåžåšãç¡ç ãæŽ»åéã«åœ±é¿ããã®ãããå¥åº·ã¯æå¿ã®åŒ·ãã ãã§ã¯æ±ºãŸãããæ®ããç°å¢ã®åœ±é¿ã倧ããåããã®ããã
ãã ããããã¯å人ã®åªåã§ç°¡åã«ã³ã³ãããŒã«ã§ããªãéšåã§ãããã®ãããã ãããããã³ã³ãããŒã«ã§ããç¯å²ïŒå®€å ç°å¢ã®æŽåãç©ºæ°æž æµæ©ãéšé³å¯Ÿçãé©åãªæž©åºŠç®¡çïŒã«éäžãã€ã€ã瀟äŒå šäœãšããŠã¯éœåžèšç»ãå ¬è¡è¡çæ¿çã®æ¹åãæ±ããããåéã§ãããã®ãããã
ð§žãå人ã®åªåã ãããã©ãã«ããªããªãããšããããã ãã
ð»ââïžããããããã ããããLongevityã¯å人ã®å¥åº·æ³ã§ãããšåæã«ã瀟äŒçãªèª²é¡ã§ãããã®ããã”ã²ãšãã®å”㚔瀟äŒã®å”ã®äž¡èŒªãå¿ èŠãªã®ãããð»ââïžã£ïŸïŸïœŒïœ¯ã
ð»ââïžð Longevityã®ãŸãšã
ð§žãããããŸã¡ããããã¡ããã¡ãé·ãã£ããã©âŠçµå±Longevityã£ãŠäœããã¡ã°ã倧äºãªã®ïŒã
ð»ââïžãïŸïœ«ïŸïœ«ããããèããŠãããã®ãLongevityãšã¯è¥è¿ãã®éæ³ãæ¢ãããšã§ã¯ãªããèåã®ä»çµã¿ãçè§£ããããã§ãæ¥åžžã®ç©ã¿éããæé©åããŠããèãæ¹ãªã®ããã第1å±€ã®12ã®Hallmarkã¯äœå ã§äœãå£ããŠãããã®å°å³ã第2å±€ã®12ã®å®è·µé åã¯ãã®å£ããŠããããã»ã¹ãé ãããããã®ããã²ãŒã·ã§ã³ããããŠã©ããã²ãšã€ã§ã¯ãªãããã¹ãŠãé£åããŠããã®ãå³åãªã®ãããã
ð§žãã²ãšã€ã«çµããªããŠããã£ãŠããšïŒã
ð»ââïžãéãããã²ãšã€ã«çµã£ãŠã¯äžååãªã®ãããéåãæ é€ãç¡ç ã瀟äŒçã€ãªãããã¡ã³ã¿ã«ã±ã¢âŠã©ããïŒã€ã§ã¯ãªããæ¥åžžã®ãã¹ãŠãé£åããŠLongevityã圢äœã£ãŠããã®ãããå®ç§ãç®æãå¿ èŠã¯ãªãã仿¥ã§ããããšãã²ãšã€ã ãã§ãå§ããã°ãããã20幎åŸã®èªåãå€ããã®ãããâšã
ð§žããªããLongevityã£ãŠãç¹å¥ãªäººã®ããã®ãã®ãããªããŠãæ®éã®äººã®æ®éã®æ¯æ¥ã®ããã®ãã®ãªãã ãã
ð»ââïžãïŸïœ¯ïŸïœ°ããããäžçªã®æ£è§£ããïŒð»ââïžã£ïŸïŸïœŒïœ¯ çã1æ¥ã§ãé·ããèªç«ããçæŽ»ãéããããã«ââãããLongevityã®é¡ããªã®ãããðã
ð»ââïžð èŠãæ¹ã³ãŒããŒ ïœ 12ã®Hallmarkãããããšèšæ¶ãããã ïœ
ð èªååãã ãã®1ïŒé æåã§èŠãããã²ããšããªãšããµã«ãµã€ãã£ã
12ã®Hallmarkã®é æåã䞊ã¹ããšïŒ ã²ãã äžå®å®æ§ã»ããã¡ã¢ççž®ã»ãšããžã§ããã£ãã¯å€åã»ããããªã¹ã¿ã·ã¹ç Žç¶»ã»ãªãŒããã¡ãžãŒäžå šã»ãšãã«ã®ãŒæç¥ç°åžžã»ããã³ã³ããªã¢é害ã»ãµã€ããŠèåïŒçްèèåïŒã»ã«ã³ãµã€ããŠæ¯æžïŒå¹¹çŽ°èæ¯æžïŒã»ãµã€ããŠééä¿¡ç°åžžã»ã€ã³ãã©ã¡ã€ãžã³ã°ïŒæ ¢æ§ççïŒã»ãã£ã¹ãã€ãªãŒã·ã¹
èªåïŒãã²ãã¢ã ãšãã㳠眮ããŠãããµã«ããããããã£ããŒã ïŒã²ã»ãã»ãšã»ãã»ãªã»ãšã»ãã»ãµã»ã«ã»ãµã»ã€ã»ãã£ïŒ
ã€ã¡ãŒãžïŒã²ãã¢ãæççšã®ãšããã³ãè±ãã§çœ®ããŠãããµã«ãããšãããããªãã£ããŒã«åºãããå Žé¢ãæ³åããã®ããããæ±ããã®ïŒèåã®åå ïŒãè±ãæšãŠãŠãããããªé£äºïŒLongevityïŒã«åããããšããã¹ããŒãªãŒã§èŠããããïŒ
ð èªååãã ãã®2ïŒ3ã«ããŽãªåé¡ã§èŠãããæ ¹ã»å¹¹ã»æã
López-OtÃnãã®è«æã§ã¯12ã®Hallmarkã3ã€ã®ã«ããŽãªã«åé¡ããŠããã®ããã
ð± æ ¹ã£ãïŒPrimary/åå åïŒïŒâ ã²ãã äžå®å®æ§ãâ¡ããã¡ã¢ççž®ãâ¢ãšããžã§ããã£ãã¯å€åãâ£ããããªã¹ã¿ã·ã¹ç Žç¶»ãâ€ãªãŒããã¡ãžãŒäžå š â èªåïŒãæ ¹ãè ããš ããã£ãš ãšããœãŒã ãããã€ã³ èœã¡ãã ïŒã²ãã âæ ¹ããããã¡ã¢âããã£ãšããšããžã§ããã£ãã¯âãšããœãŒããããããªã¹ã¿ã·ã¹âãããã€ã³ããªãŒããã¡ãžãŒâèœã¡ãïŒ
ð¿ å¹¹ïŒAntagonistic/æ®æåïŒïŒâ¥æ 逿ç¥ç°åžžãâŠããã³ã³ããªã¢é害ãâ§çްèèå â èªåïŒãæ é€ãã¹ã£ãŠ çŽ°èèããã ïŒæ é€âæ 逿ç¥ããã¹âããã³ã³ããªã¢ã现èèããâ现èèåïŒ
ð æèïŒIntegrative/çµ±ååïŒïŒâšå¹¹çŽ°èæ¯æžãâ©éä¿¡ç°åžžãâªæ ¢æ§ççãâ«ãã£ã¹ãã€ãªãŒã·ã¹ â èªåïŒãå¹¹éšã®éä¿¡ çããŠãã€ãã€ã ïŒå¹¹éšâ幹现èãéä¿¡âéä¿¡ç°åžžãçããŠâæ ¢æ§ççããã€ãã€âãã£ã¹ãã€ãªãŒã·ã¹ïŒ
ð èšåºLongevity12é ç®ã®èŠãæ¹
ãéã»å¿ã»çã»æ ã»ç¡ã»äœã»è¡ã»è³ã»è³ç®ã»ç€Ÿã»å¿ã»ç°ã
èªåãã®1ïŒãããããããããããããäœè¡è³ã¿ã¿ã瀟å¡ã®ã·ã³ã«ã³ïŒæ°å¹¹ïŒç·ã ïŒéåã»å¿èºã»çåã»æ é€ã»ç¡ç ã»äœéã»è¡å§è¡ç³è質ã»è³ã»è³ç®ã»ç€ŸäŒã»å¿ïŒã¡ã³ã¿ã«ã»ç°å¢ïŒ
èªåãã®2ïŒãé転 å¿é çè æ é€ ç¡ç 倪ã è¡æ¶² è³ è³ç® 瀟亀 å¿ ç°å¢ã â ã¹ããŒãªãŒïŒãé転ã§å¿é ãªçèã¢ãªã¢ãªã®å€ªãã®äººããè¡æ¶²æ€æ»ã§è³ãšè³ç®ã蚺ãŠãããã瀟亀çãªå¿ã§ç°å¢ãå€ããã
ð è¶ éèŠããŒã¯ãŒãïŒæ¡æãŸãšã
López-OtÃn et al., 2013 â “The Hallmarks of Aging” â Cellèª â 9ã€ã®Hallmark èŠãæ¹ïŒã13幎ïŒãã ãããïŒãããã¹9ïŒãã ãïŒæ¡ãïŒ2013幎ã«López-OtÃnã9ã€å®çŸ©ïŒ
López-OtÃn et al., 2023 â “Hallmarks of Aging: An Expanding Universe” â Cellèª â 12ã®Hallmark èŠãæ¹ïŒã23幎ïŒã«ãã ãããïŒãããã¹12ïŒãã ãã«ïŒå®å®ãïŒ2023幎ã«12ã«æ¡åŒµã”Expanding Universe”ã ããå®å®ïŒ
远å ããã3ã€ïŒãªãŒããã¡ãžãŒã»æ ¢æ§ççã»ãã£ã¹ãã€ãªãŒã·ã¹ èŠãæ¹ïŒããªããã£ïŒããŸãDiïŒãïŒãªïŒãªãŒããã¡ãžãŒããïŒæ ¢æ§ççããã£ïŒãã£ã¹ãã€ãªãŒã·ã¹ïŒ éæ¹åããã¯ïŒããåãDIYïŒèªåã§çŽãïŒãâ ãªãŒããã¡ãžãŒïŒèªåã§æé€ïŒãæ ¢æ§ççïŒèªåã§æ¶ç«ïŒããã£ã¹ãã€ãªãŒã·ã¹ïŒèªåã§è žãæŽããïŒïŒ ãã¹ãŠãèªå·±ç®¡çããéµ
SASPïŒSenescence-Associated Secretory PhenotypeïŒïŒçްèèåé¢é£åæ³è¡šçŸå èŠãæ¹ïŒãSASPã£ãšïŒãã£ãšïŒççãŸãæ£ããã éæ¹åããã¯ïŒããµã¹ãã³ã¹ïŒSASP+enseïŒãïŒ èå现èã”ãµã¹ãã³ã¹ãã©ãã®ç¯äºº”ã®ããã«éãã«åšå²ãå£ããŠãã
mTORçµè·¯ïŒæ 逿ç¥ã®åžä»€å¡ èŠãæ¹ïŒãm(ãã£ãš)TO(é£)R(ã)ãïŒ mTORãæŽ»æ§åãããšããã£ãšé£ãããã£ãšæé·ããããšã·ã°ãã«ãéãç¶ãã éæ¹åããã¯ïŒãã©ããã€ã·ã³ã§mTORãã©ããïŒRAPAïŒå¹ããŠæ¢ããã
ã»ããªãã£ã¯ã¹ïŒSenolyticsïŒïŒèå现èé€å»è¬ èŠãæ¹ïŒãã»ãïŒseno=èåïŒãªãã£ã¯ã¹ïŒlytic=溶ããïŒãïŒãèããæº¶ããã éæ¹åããã¯ïŒãè害瀟å¡ãSENO(è§£é)LYTICS(ãªã¹ãã©)ããã
ð»ââïžâš 以äžãLongevityå®å šè§£èª¬ããããã¬ãã®å¥åº·å¯¿åœã1æ¥ã§ãé·ããè±ãã§ããããšããããã¯å¿ããé¡ã£ãŠãããããä»å€ããããæ±ããŠãã£ããç ãã®ããããç¡ç ããæé«ã®LongevityæŠç¥ãªã®ããããã®ðð»ââïžð€
ð ãPRãçŸããæªæ¥ãžã®æè³ïŒå¿ããæ¹åãFXã·ã°ãã«é ä¿¡
çŸå®¹ã«ãéããããããã«ãå°æ¥ã®èªåãžã®æè³ã倧åãå¿ããçŸå®¹é¢ä¿è ã«ã人æ°ã®ãåãåãã ããã·ã°ãã«é ä¿¡ã§ãã¹ããŒãã«è³ç£åœ¢æããŸãããïŒ
- ð¥ äžåºŠãã3,980åïœããã·ã°ãã«ãæ°žä¹ ååŸïŒ
- ð è²·ãåãäŸ¡æ Œã ããå®å¿ïŒè¿œå æéäžåãªã
- ð¯ æé¡ãããªãããè§£çŽã®å¿é ãŒãïŒ
âš ã¹ããŒãæè³è¡ïŒå¿ãã女æ§ã®ããã®ã·ã°ãã«æè³è¡ â€